Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
86(5):969-77
McMurray JJV
on head and neck squamous cell carcinoma cells
2 nM) in inhibiting isoproterenol-induced cAMP production in HEK-293 cells
LCZ696 treatment significantly reduces LPS-induced intracellular ROS and MDA levels
Ibandronate Sodium Catalog No.:M8787-2 86(5):969-77Ibandronate sodium is a potent bisphosphonate drug developed by Hoffman La Roche and used in the prevention and treatment of osteoporosis and metastasis associated skeletal fractures in people with cancer. It may also be used to treat hypercalcemia (elevated blood calcium levels). Ibandronate is indicated for the treatment and prevention of osteoporosis in post menopausal women. In May 2003, the U. S. Food and Drug Administration (FDA) approved
US$ 145.00
US$ 100.00
US$ 125.00
US$ 114.00
US$ 20.00
US$ 38.00
US$ 62.00
US$ 40.95
US$ 120.00
US$ 44.00
US$ 56.99
US$ 65.00
US$ 72.00
US$ 38.00
US$ 38.00